Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 11, 2025 · Filed Feb 12, 2025
Biodesix's Chief Commercial Officer sold $16K of Biodesix shares. The filing references vesting of compensation awards.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$16,198
Shares × reported transaction price
32 days after results of Jan 10, 2025, 20 days before results of Mar 3, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −4.4% | +0.1% | −4.5% |
| 30 days | −22.1% | −7.0% | −15.2% |
| 90 days | −77.2% | −3.6% | −73.5% |
| 180 days | −57.3% | +5.4% | −62.7% |
| 365 days | −40.5% | +11.8% | −52.4% |
Past results only. Not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
